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Abstract
Forkhead box N1 (FOXN1) is a transcription factor crucial for thymic epithelium development and prevention of its
involution. Investigation of a patient with a rare homozygous FOXN1 mutation (R255X), leading to alopecia universalis and
thymus aplasia, unexpectedly revealed non-maternal circulating T-cells, and, strikingly, large numbers of aberrant double-
negative ab T-cells (CD4negCD8neg, DN) and regulatory-like T-cells. These data raise the possibility that a thymic rudiment
persisted, allowing T-cell development, albeit with disturbances in positive/negative selection, as suggested by DN and
FoxP3+ cell expansions. Although regulatory-like T-cell numbers normalized following HLA-mismatched thymic
transplantation, the abDN subset persisted 5 years post-transplantation. Involution of thymus allograft likely occurred 3
years post-transplantation based on sj/bTREC ratio, which estimates intrathymic precursor T-cell divisions and,
consequently, thymic explant output. Nevertheless, functional immune-competence was sustained, providing new insights
for the design of immunological reconstitution strategies based on thymic transplantation, with potential applications in
other clinical settings.
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Introduction
The thymus is a primary lymphoid organ essential for normal
T-cell development. The unique ability of the thymic microenvi-
ronment to generate and select T-cells requires a specialized
epithelium that is regulated by forkhead box N1 (FOXN1) [1–4].
This transcription factor is expressed by the thymic anlage that
emanates from the epithelium of the pharyngeal pouch, and is
required for the differentiation of thymic epithelial cells [1,2].
Thymic epithelium comprises two main compartments defined by
their position and functional characteristics: the cortex, and the
medulla, the latter being thought to be fundamental for the
negative selection of auto-reactive thymocytes and the generation
of central tolerance. The cortical and medullary epithelia have
been shown, in mice, to differentiate from a common epithelial
progenitor that expresses FOXN1 [4]. Additionally, continuous
FOXN1 expression was shown to be essential for both the
maintenance of thymopoiesis in the murine postnatal period [4],
and the prevention of thymic involution during adulthood [3,5],
highlighting FOXN1 as an important target for immune
reconstitution strategies. Mutations in FOXN1 lead to athymia
together with total alopecia, due to the additional role of FOXN1
in hair follicle differentiation [1,2,6].
Human FOXN1-deficiency was first reported by Pignata et al. in
two sisters from Campania, Italy [7,8]. Notwithstanding the
evidence of athymia, a significant number of circulating T-cells
was observed in these children with close to normal numbers of
CD8 T-cells [9]. We identified the same homozygous R255X
mutation [7,9,10], in a Portuguese child, who presented at 5
months with total alopecia and Bacillus Calmette-Gue ´rin (BCG)
dissemination, following routine neonatal vaccination with this
live-attenuated mycobacterium, that also presented with a
significant pool of circulating non-maternal T-cells [11]. This
child underwent HLA mismatched thymic transplantation with
evidence of functional immunologic reconstitution, as we recently
reported [11].
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37042The aim of this work was to investigate the T-cell compartment
of this FOXN1-deficient child and the mechanisms underlying the
immunological reconstitution upon thymic transplantation. Our
findings suggest that T-cell development can occur in a putative
FOXN1-deficient thymus rudiment, albeit with altered positive and
negative selection as suggested by the marked expansion of T-cells
expressing the alpha-beta T-cell receptor (TCR) in the absence of
both CD4 and CD8 expression (double-negative DNab) together
with an over-representation of T-cells of a regulatory-like
phenotype expressing high levels of FoxP3 in conjunction with
other regulatory markers. Notwithstanding, an extrathymic origin
of the altered T-cell populations cannot be discarded. We also
showed that the transplantation of HLA-mismatched FOXN1
competent thymic epithelium led to the achievement of sustained
immune-competence despite evidence of involution of the
allogeneic thymus 3 years post-transplantation. We believe that
these data on the follow-up of this unique clinical case contribute
significantly to the debate on the mechanisms underlying T-cell
development and immune reconstitution that may help in the
design of new therapeutic approaches in other clinical settings.
Methods
Patient
Female child, born at term to consanguineous Portuguese
parents, admitted at day 157 of life with respiratory failure due to
Bacillus Calmette-Gue ´rin (BCG) dissemination, following routine
neonatal BCG vaccination. The FOXN1 mutation identified is a
homozygous C-to-T transition at nucleotide position 792 (Gen-
Bank accession no. Y11739) leading to a nonsense mutation at
residue 255 (R255X) in exon 4, formerly exon 5 [10]. Maternal
chimerism was assessed using AmpFISTR Identifiler PCR
Amplification Kit (Applied Biosystems, detection limit 1/100).
The patient’s clinical data were the focus of another manuscript
[11]. Failure to thrive and progressive nutritional status deterio-
ration were observed despite antibiotic/tuberculostatic therapy
and intravenous immunoglobulin G. Thymus transplantation was
performed (day 424 of life), under protocols approved by the Duke
Institutional Review Board (IRB) and reviewed by the Food and
Drug Administration under an Investigational New Drug (IND)
application, as described [11]. Unrelated allogeneic thymus tissue,
routinely discarded from infants less than 9 months of age
undergoing cardiac surgery, was used for transplantation after
informed consent [12–14].
Ethics
Studies were performed with parent’s written informed consent
under the ethical guidelines of Hospital Universita ´rio de Santa
Maria, Faculdade de Medicina da Universidade de Lisboa, and
the Duke University Health Systems. The Ethical Board of the
Hospital Universita ´rio de Santa Maria, Faculdade de Medicina da
Universidade de Lisboa specifically approved this study.
Cell isolation and cell sorting
Peripheral blood mononuclear cells (PBMC) were isolated
immediately after collection by Ficoll-Hypaque. Naı ¨ve CD4+ T-
cells were sorted using the EasySep CD4+ naı ¨ve T-cell enrichment
magnetic kit (StemCell Technologies). DNab and CD8 T-cells
were isolated using the BD FACSAria High Speed Cell Sorter (BD
Biosciences) after surface staining for CD3, CD4, CD8, TCRcd
and TCRab. Population purity after sorting was greater than
98%.
Flow Cytometry
Lymphocyte subsets were characterized using fresh whole blood
after acquiring at least 100,000 events within a lymphogate using a
FACSCalibur flow cytometer (BD Biosciences). TCR Vb family
frequency was quantified in whole blood using IOTest Beta Mark
(Beckman Coulter). PBMC were stained intracellularly for CTLA-
4 (clone BNI3) and/or Ki-67 (clone MOPC-21) both from BD
Biosciences, and FoxP3 (clone PCH101) using eBiosciences’s kit
after surface staining, as described [15]. FoxP3 expression post-
transplant was assessed in fresh PBMC, whereas cryopreserved
PBMC were used for time-points prior to thymic transplantation.
Apoptosis was assessed in fresh PBMC using Annexin V-FITC
Apoptosis Detection Kit (BD Biosciences) and propidium iodide
(PI) staining. Analysis was done using FlowJo software (TreeStar).
Results were expressed as median intensity of fluorescence (MFI)
of a molecule or percentage of positive cells, and absolute numbers
calculated by multiplying their percentage by the absolute
lymphocyte count.
Assessment of cytokine production at the single-cell level
Cytokine production was assessed at single-cell level after 4 h
PBMC culture with PMA/ionomycin in the presence of brefeldin
A, as described [16], with mAb against IFN-c (clone 4S.B3), IL-2
(clone MQ1-17H12), and IL-4 (clone MP4-25D2) from BD
Biosciences; IL-10 (clone JES3-9D7); and IL-17 (clone eBio64-
DEC17) from eBiosciences.
STAT5 tyrosine phosphorylation analysis
STAT-5 phosphorylation (p-STAT5) was evaluated by flow
cytometry on fresh PBMC stimulated for 15 min with IL-7
(50 ng/ml), IL-2 (100 U/mL) or IL-15 (25 ng/ml) or medium
alone as described [17].
Proliferative responses to cytokines
Fresh PBMC were stimulated with IL-7 (10 ng/ml), IL-2
(10 U/mL), IL-15 (12.5 ng/ml), immobilized anti-CD3 (1 mg/ml)
plus anti-CD28 (1 mg/ml) or medium for 5 d. The fold change in
percentage of Ki-67+ cells and CD25 MFI with respect to medium
alone were evaluated by flow cytometry on gated DNab, CD4+
and CD8+ T-cells.
TCR – chain CDR3 spectratyping
Total RNA was extracted from 10
5 to 10
6 cells with RNeasy kit
(Qiagen) and first strand cDNA synthesized from 1–2 mg of RNA
with the Superscript III kit (Invitrogen) using an equivolume
mixture of random hexamers and oligo (dT). Amplification of the
TCRVb CDR3 was performed using primers specific for each Vb
family [18] except for Vb6 and Vb21 [19] and a common Cb
reverse primer [18]; followed by a run-off reaction that extends
each different PCR product with a constant Cb FAM labeled
primer; and a third step, in which each different Vb PCR labeled
fragment was separated using a capillary electrophoresis based
DNA automated sequencer. Data were collected and analyzed
with GeneMapper v4.0 (Applied Biosystems) for size and
fluorescence intensity determination.
TREC analysis
Signal joint (sj) and DbJb T-cell receptor rearrangement
excision circle (TREC) analyses were conducted as described
[20,21]. Briefly, triplicate multiplex PCR amplification for
sjTREC, DJb1TRECs (Db1-Jb1.1 to 1.6) or DJb2TRECs (Db2-
Jb2.1 to 2.7), together with the CD3c chain were performed on
lysed PBMC. TREC and CD3c quantifications were then
T-Cells in Human FOXN1-Deficiency
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TM in independent experiments,
with the same first-round serial dilution standard curve. This
highly sensitive nested quantitative PCR assay allowed detection of
one copy in 10
5 cells for any excision circle. The sj/bTREC ratio,
(sjTREC/10
5cells/(DJb1TRECs/10
5cells+DJb2TRECs/
10
5cells)), was calculated as described [20].
Results
Abnormal expansion of DNab and FoxP3
bright T-cells in
human FOXN1-deficiency
Circulating T-cells of non-maternal origin were documented at
close to normal numbers (2219 cells/ml) at 5 months of age in a
child with a homozygous R255X mutation in the FOXN1 gene, as
we recently reported [11]. The T-cell compartment exhibited
similar proportions of CD4+, CD8+ and, ab-cells that expressed
neither CD4 nor CD8 (double-negative, DNab), which usually
represent less than 1% of circulating T-cells. Athymia was
diagnosed based on absent thymus-shadow on x-ray, lack of naı ¨ve
T-cells, and undetectable levels of products of TCR rearrange-
ments in the thymus, specifically signal-joint TCR excision circles
(sjTREC) [11]. Here, we aimed to further investigate the
phenotype and the function of these T-cells developed in the
context of a putative athymia. We found that CD4+ T-cells
exhibited an activated memory-effector phenotype with preserved
IL-2, IFN-c and IL-4 production (Figure 1A). CD8+ T-cells
featured a similar activated phenotype, with no terminal-effector
differentiation, as illustrated by the maintenance of CD45RO/
CD28/CD27 expression (Figure 1B) and the low frequency (3%)
of perforin-producing cells (Figure 1B). The aberrantly expanded
DNab T-cells (676 cells/ml) also expressed CD45RO, most were
CD27+, and produced IL-2 (Figure 1C), in agreement with a lack
Figure 1. Peripheral T-cells prior to thymus transplantation in a patient with R255X FOXN1 mutation. At day 166 of life there were 10.4%
(660 cells/ml) CD4 T-cells, 9.7% (612 cells/ml) CD8 T-cells; and 10.7% (676 cells/ml) DNab T-cells in the peripheral blood. CD4+ (A), CD8+ (B), and DNab
T-cells (C) exhibited a memory-effector activated phenotype and were able to produce significant amounts of IL-2, IFN-c and IL-4. (D) Percentages of
cycling cells, as assessed by Ki-67 expression, within CD8, CD4, DNab and cd T-cells. (E) Dot-plots showing that: FoxP3 expression is restricted to CD3+
cells; that within total FoxP3+ cells (328 cells/ml) there were 67% CD4+, 17% DNab and 12% cells co-expressing CD4 and CD8 (DP, DP represented 3%
of total ab cells and 26% of them were FoxP3+) as illustrated by the expression of CD4 and CD8 within total ab cells (grey) and within FoxP3+ cells
(black); the concomitant expression of FoxP3 with other Treg markers (CTLA-4, CD39), or Ki-67 within total CD4+ T-cells; and the lack of cytokine
production by FoxP3+ cells. (F)V b distribution within FoxP3+ and FoxP32 CD4 T-cells performed at day 254 of life. Graphs show the proportion of
FoxP3+ CD4 T-cells and FoxP32 CD4 T-cells belonging to a given Vb family as assessed by flow cytometry. Dot-plots show analysis after gating on the
respective populations; numbers within each quadrant represent the proportion of cells expressing the respective molecules. Cytokine production
was assessed after 4 hours stimulation of PBMC with PMA plus Ionomycin in the presence of Brefeldin A.
doi:10.1371/journal.pone.0037042.g001
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T-cells were cycling (Figure 1D). It is likely that IL-7 played a role
in T-cell maintenance/expansion given their preserved expression
of the IL-7 receptor a-chain (IL-7Ra), as illustrated for CD4 T
cells in Fig. 1A, and lack of elevated serum IL-7 levels (6.3 pg/ml,
209 days pre-transplantation). IL-7 serum levels typically increase
in lymphopenic settings [17]. In agreement with the evidence of
IL-7 use, IL-7 serum levels were not increased before transplan-
tation, and increased transitorily to 44.3 pg/ml (133 days post-
transplantation) during T-cell depletion in the peri-transplantation
period.
The thymus is known to produce a regulatory CD4+ T-cell
subset (Treg), fundamental for preventing autoimmunity, currently
best identified by expression of the forkhead box P3 transcription
factor (FoxP3) [22–25]. We found that up to 40% of the CD4
subset (328 cells/ml) expressed high levels of FoxP3, and observed
atypical populations of FoxP3+ DNab and double-positive T-cells
(Figure 1E). FoxP3 can also be up-regulated in non-Treg T-cells
upon activation [24,26]. Nonetheless, several findings support
these cells being bona fide Treg. In agreement with human Treg
phenotype [24], they expressed FoxP3 at high intensity concom-
itantly with other Treg-associated markers, namely CTLA-4 and
CD39 (Figure 1E). Moreover, in contrast to activated T-cells, they
did not produce IL-2 or IFN-c (Figure 1E). The limited amount of
blood samples precluded suppressive assays as well as the
evaluation of Treg-like cell repertoire by CDR3 sequence analysis.
Of note, comparison of the relative representation of different Vb
families within the FoxP3+ and FoxP32 CD4 sub-populations
revealed a skewed repertoire in both populations but with distinct
oligoclonal expansions in each, providing further support that
these FoxP3+ cells represented a separate CD4 lineage (Figure 1F).
Thus, despite the presence of FOXN1-deficiency, we observed a
reasonable number of circulating non-maternal T-cells associated
with oligoclonal expansions of DNab and FoxP3+ T-cells. The
Figure 2. Immunological reconstitution and Treg recovery after thymic transplantation in a patient with R255X FOXN1 mutation. (A)
Kinetics of the frequency of naı ¨ve cells (CD45RA+CD27+) within CD4 and CD8 T-cell subsets; histogram shows CD31 expression within naı ¨ve CD4 T-
cells at 58 months post-transplant, a marker associated with recent thymic emigrants. (B) Longitudinal quantification of sjTREC (left) and sj/bTREC
ratio (right) quantified in total PBMC. (C) Assessment of TCR repertoire by spectratyping analysis of the CDR3 Vb regions of purified naı ¨ve CD4 T-cells
at 59 months post-transplant. (D) Representative dot-plots of the longitudinal analysis of the frequency of cells expressing FoxP3 and/or CD25 within
total CD4 T-cells (upper dot-plots), and the phenotype of circulating FoxP3+ cells at 36 months post-transplant after successive gates on CD4+ and
FoxP3+ T-cells (lower dot-plots); numbers inside quadrants represent the frequency of cells expressing the indicated molecules. (E) Graph shows the
proportion of circulating FoxP3+ and FoxP32 CD4 T-cells belonging to each of the Vb families at 48 months post-transplantation analysed by flow
cytometry.
doi:10.1371/journal.pone.0037042.g002
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rudiment supporting a perturbed T-cell development, or, alterna-
tively, that extrathymic sites of lymphopoiesis could be involved in
T-cell development in the context of a congenital absence of the
thymus.
Sustained immune-competence was achieved upon HLA
mismatched thymic transplantation despite involution of
thymus allograft
As FOXN1 mutations impact on thymic epithelium rather than
on hematopoietic precursors, we predicted that thymic transplan-
tation, although never previously performed in this setting, could
provide a curative strategy. As shown in our previous clinical
report [11], the efficacy of the thymic transplantation performed
was best demonstrated by the temporal association between the
clearance of ongoing BCG adenitis and the development of PPD-
specific proliferative responses. We continued to follow the child
and confirmed that she remained free of significant infections 5
years after cessation of all prophylactic therapies. Here, we aimed
to further investigate the kinetics of T-cell recovery upon HLA-
mismatched thymic transplantation and its relationship with
output of the thymic explants.
A slow progressive increase in the proportion of circulating
naı ¨ve CD4+ T-cells, mainly expressing CD31, a marker associated
with recent-thymic emigrants [17], was observed (Figure 2A),
accompanied, as expected, by an increase in sjTREC levels within
total PBMC (Figure 2B). Despite the HLA-mismatch of the thymic
epithelia, naı ¨ve CD4+ T-cells showed a fully diverse TCR
repertoire 5 years post-transplantation (Figure 2C), confirming
the trend shown in our previous report within total CD4 T-cells
[11].
The expanded Treg-like cells disappeared during the peri-
transplant period and a parallel reconstitution of the Treg pool
and CD4 subset was observed, leading to stable frequencies within
the normal range (Figure 2D) as well as absolute counts (44 cells/
ml, 36 months post transplantation). Of note, distribution of Vb-
families within FoxP3+ and FoxP32 CD4+ T-cells was very
similar despite the HLA-mismatch between thymic epithelia and
host (Figure 2E).
CD8+ T-cell recovery was disproportionally low compared to
CD4 T-cells (92 cells/ml, 9% of T-cells, 5 years post-transplan-
tation), confirming our previous report [11]. Nevertheless, we
show here that the kinetics of naı ¨ve cell expansion within CD8+
subset paralleled those observed for their CD4+ counterparts
(Figure 2A). In agreement, we found similar sjTREC levels in
purified CD4+ and CD8+ T-cells (7155 and 7540 sjTREC/10
5
cells; respectively, 30 months post-transplantation). A poor CD8
recovery has been described following HLA-mismatched thymic
transplantation in DiGeorge syndrome [12,13], possibly related to
the full HLA class I mismatch between host hematopoietic
precursors and allogeneic thymic epithelia or to alterations in the
thymic graft associated with transplantation procedures. Never-
theless, the transplant-derived CD8+ T-cells were apparently
functional in this child [11], as documented by the transitory
expansion of terminally differentiated CD8 T cells during
Varicella Zoster virus infection (Figure 3).
Additionally, in order to estimate the functionality of the
allogeneic thymic graft we quantified, for the first time in the
context of thymic transplantation, the sj/bTREC; a ratio between
early and late products of TCR rearrangements providing an
indirect measurement of thymocyte division-rate and a direct
correlate of thymic output [20,27,28]. Whilst very low during the
peri-transplant period, the sj/bTREC ratio increased progressively
(Figure 2B), reaching levels comparable to those observed in
healthy children, 2.5 years post-transplant. Of note, a sharp
decline in sj/bTREC was observed 4 years post-transplantation
(Figure 2B). This was accompanied by a modest decrease in
sjTREC levels within total PBMC and in the proportion of naı ¨ve
cells, supporting the decline in thymic allograft output (Figure 2A–
B). These values plateaued thereafter (Figure 2A–B), suggesting
Figure 3. Reduced but functional CD8+ T-cell compartment after fully-mismatched HLA class I thymus transplantation. (A) Circulating
CD8+ ab T-cells analysed 58 months post-transplantation (5% of total lymphocytes; 83cells/ml) by flow cytometry in terms of: naı ¨ve/memory/effector
phenotype assessed by CD45RA and CD27 expression; levels of activation markers (CD38 and HLA-DR); IFN-c and IL-2 production upon
PMA+ionomycin stimulation; ex vivo frequency of cycling cells (Ki-67+); and ex vivo frequency of apoptotic cells assessed by annexin V staining. (B)
TCR repertoire diversity evaluated by spectratype of CDR3 Vb regions of purified CD8+ T-cells at 59 months post-transplant. (C) Graph shows the
coordinate increase in the proportion of terminally differentiated effector cells defined as CD45RA+CD27neg cells within total CD8+ T-cells during
acute varicella infection and its decrease in parallel with its clinical resolution.
doi:10.1371/journal.pone.0037042.g003
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of the immune system.
These data provide novel evidence that immune-competence
can be achieved in the absence of long-term sustainability of
thymic output from the allogeneic tissue, with implications for
other clinical settings aimed at immunological reconstitution.
Persistence of circulating DNab T-cells despite the
immunological recovery upon thymic transplantation
We also investigated the fate of the DNab T-cell population that
was markedly expanded pre-transplantation [11]. In contrast with
the recovery of all T-cell subsets, a significant population of
circulating DNab persisted, at relatively stable numbers (range
125–548 cells/ml throughout the follow-up) [11], being 188 cells/
ml at 6-years post-transplantation (Figure 4A).
DNab cells maintained a similar memory phenotype, being all
CD45RO+ (Figure 4B), and skewed repertoire, as assessed by
spectratyping (Figure 4C), throughout the follow-up period. They
also displayed no evidence of terminal-effector differentiation as
indicated by their preserved ability to produce IL-2 in the absence
of significant amounts of effector cytokines such as IFNc, IL-4, IL-
10 or IL-17, following short-term PMA/Ionomycin stimulation
(Figure 4D), as well by their preserved expression of CD27, in the
absence of CD57 and perforin (Figure 4E). A potential ability for
mucosal homing was suggested by significant expression of CCR6
and CD103 (Figure 4B), which was of even more interest given
that DNab cells neither produced IL-17 (Figure 4D) nor expressed
the Treg markers FoxP3 or CTLA-4 (Figure 4F). Their levels of
CD38 and HLA-DR expression were low (Figure 4F), suggesting
that they were not in an activated state.
Importantly, DNab cells expressed high levels of CD25, the IL-
2 receptor a-chain, in conjunction with CD127, the IL-7 receptor
a-chain (Figure 5A). Moreover, they showed higher levels of Bcl-2
expression than CD4 and CD8 T-cells (Figure 5B), suggesting in
vivo responsiveness to IL-7. To test this hypothesis we quantified
the levels of STAT-5 phosphorylation (p-STAT-5) within DNab,
CD4 and CD8 T-cells upon short-term exposure to IL-7, IL-2 or
IL-15 in vitro. As shown in Figure 5C, DNab cells exhibited the
highest levels of p-STAT-5 upon IL-2 or IL-7 stimulation and
were not responsive to IL-15. Additionally, freshly isolated PBMC
were cultured in the presence and in the absence of these cytokines
as well with anti-CD3 plus anti-CD28 mAb as a positive control
for T-cell stimulation. We found that, as for CD4 T-cells, DNab
cells up-regulated CD25 expression upon IL-7 stimulation in vitro
(Figure 5D), but showed no distinct proliferative abilities, as
Figure 4. Persistence of DNab T-cells in a patient with R255X FOXN1 mutation after thymic transplantation. (A) Absolute counts and
proportion of DN, CD8+, CD4+ cells within circulating ab+ T-cells 59 months post-transplantation. Analysis of DNab T-cells revealed: (B) a relatively
undifferentiated memory phenotype with increased expression of mucosal homing molecules; (C) a skewed repertoire as assessed by spectratype of
CDR3 Vb regions; (D) reduced ability to produce IFN-c, IL-4, or IL-17 but high IL-2 production upon PMA+ionomycin stimulation; (E) no terminal-
effector differentiation according to CD27, CD57 and perforin expression (histogram compares perforin levels within DNab, CD8 and CD4 T-cells); (F)
reduced levels of the activation markers CD38 and HLA-DR and absence of Treg-associated markers despite the increased levels CD25 expression,
Numbers inside dot-plots represent frequency of cells expressing the indicated molecules acquired with FACSCalibur flow cytometer.
doi:10.1371/journal.pone.0037042.g004
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response to these cytokines in comparison with CD4 or CD8 T-
cells (Figure 5E). Of note, they respond to TCR stimulation with
both up-regulation of CD25 (Figure 5D) and increased frequency
of cycling cells (Figure 5E). Notably, the frequency of cycling
DNab cells ex vivo was very low (Figure 5F). Thus, our findings
supported a role of IL-7 and IL-2 in DNab cell maintenance,
given their high levels of expression of IL-7 and IL-2 receptors and
ability to respond to these cytokines in vitro. Moreover, DNab cells
showed increased Bcl-2 levels in the absence of cell cycling
markers in vitro and ex vivo, suggesting that IL-7 and/or IL-2 mainly
impacted on DNab cell survival rather than their turnover.
In order to evaluate the thymic contribution for the mainte-
nance of DNab cells, we quantified the sjTREC levels in sorted
DNab cells from the peripheral blood 6 years post thymus
transplantation. The sjTREC levels were found to be very low (3.2
sjTREC/10
5 DNab cells as compared with 3783 sjTREC/10
5
sorted CD4 T cells and with 2212 sjTREC/10
5 sorted CD8 T
cells), supporting the possibility that DNab were long-lived cells
originated before the thymus transplantation.
Overall, we found that the DNab cells abnormally expanded
before thymic transplantation were maintained for up to six years
post-thymic transplantation and appeared to rely mainly on
cytokine-driven survival.
Discussion
The transcription factor FOXN1 is considered essential for the
development of the thymic epithelia and the prevention of its
involution during adulthood. Nevertheless, we demonstrated here
that human homozygous R255X FOXN1-deficiency may be
associated with significant numbers of circulating T-cells of non-
maternal origin with major expansions of DNab and FoxP3+ cells
through the study of a rare clinical case.
Our data raise important questions regarding T-cell origin in
the context of human athymia. One plausible explanation is that a
thymic rudiment may persist, facilitating a limited production of
T-cells that subsequently expanded in the periphery. In mice, the
Foxn1 gene was shown to be dispensable for the initial formation of
the thymic primordium [4,29]. There is also evidence of functional
T-cells in nude mice [30], although, at least some of these T-cells
seem to be generated extra-thymically [31]. CD4+ and CD8+ ab
T-cells accumulate with ageing in nude mice [32], but character-
ization of a putative Treg compartment has not been conducted.
We have shown that FoxP3 induction can occur in early stages of
both murine and human normal T-cell differentiation [15,25]. Of
note, significant DNab as well as FoxP3+ cells were found in a
mouse model of extra-thymic lymphopoiesis induced by Oncos-
tatin M, a cytokine that induces thymic atrophy and lymph node
alterations that support T-cell differentiation [33].
Importantly, circulating T cells of non-maternal origin were
found in all the cases described with R255X FOXN1 mutation [7–
9,11], which leads to a short N-terminal FOXN1 protein without
DNA binding domain [34]. In contrast no circulating T-cells were
found in a patient with a second mutation identified in the human
FOXN1 gene (R320W), a missense mutation of the DNA binding
domain [11]. These discrepant findings raise new hypotheses
about the role of FOXN1 in the development of the thymic
epithelium that deserve further exploration using mouse models
and comparative structural studies [1,35,36].
As all patients reported with R255X FOXN1 mutation presented
circulating T-cells [7–9,11], it is plausible that they retained a
dysplastic thymic rudiment capable of supporting T-cell differen-
tiation, albeit with a narrow TCR repertoire and impaired T-cell
selection, allowing the emergence of atypical DNab and Treg.
Alternatively, this thymic rudiment could allow T-cell commit-
ment of precursors for subsequent extra-thymic development. In
support of this possibility, progenitor T-cell commitment was
Figure 5. Ability of expanded circulating DNab T-cells to respond to IL-7 and IL-2. Representative flow cytometric analysis of freshly
isolated PBMC from a patient with R255X FOXN1 mutation 59 months after thymic transplantation illustrating (A) the preserved expression of IL-7Ra
and increased CD25 expression within DNab T-cells; and (B) the high levels of Bcl-2 expression within DNab in comparison with CD8 and CD4 T-cells.
(C) Up-regulation of p-STAT5 upon 15 min stimulation of PBMC with IL-7 (50 ng/ml), IL-2 (100 U/mL) or IL-15 (25 ng/ml), bars represent p-STAT5 MFI
within gated DNab, CD8 and CD4 T-cells. Freshly isolated PBMC were cultured for 5-day in the presence of IL-7 (10 ng/ml), IL-2 (10 U/mL), or IL-15
(12.5 ng/ml) or anti-CD3 plus anti-CD28 stimulation and graphs represent the fold change of CD25MFI with respect to medium (D), and the
frequency of Ki-67+ cells (E), within gated DNab, CD8 and CD4 T-cells. (F) Representative analysis of freshly isolated PBMC illustrating the low levels
cycling cells (Ki-67+) despite the increased CD25 expression within gated DNab T-cells. Numbers inside dot-plots represent frequency of cells
expressing the indicated molecules acquired with FACSCanto (p-STAT5 and 5-day cultures) or FACSCalibur flow cytometers.
doi:10.1371/journal.pone.0037042.g005
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development in mouse models [37].
The Treg compartment has recently been investigated in other
clinical settings associated with peripheral oligoclonal T-cell
proliferation in patients with thymic impairment either due to
hypomorphic mutations in hematopoietic precursors (Omenn
syndrome) [38–40], or to developmental defects associated with
variable degrees of thymic hypoplasia (DiGeorge syndrome)
[41,42]. In these settings, Treg frequencies appeared to be
unaltered or reduced [38–42], emphasizing the distinctiveness of
the pattern of high levels of Treg seen before transplantation in
our case of R255X FOXN1-deficiency. Remarkably, the peripheral
pool of FoxP3+ T cells normalized upon transplantation of
FOXN1 competent thymic epithelia. Thymic Treg development is
currently thought to be dependent on a small developmental niche
that tightly controls Treg output [43,44]. It is thus plausible to
speculate that FOXN1 may play a role in such niches,
contributing to the thymic regulation of Treg numbers.
The numbers of circulating DNab T-cells remained relatively
constant up to 6 years after thymic transplantation. Of note, these
cells have not been shown to expand following HLA-mismatched
thymus transplantation [11,12], and were reported to progres-
sively decline after effective naı ¨ve reconstitution in complete
DiGeorge patients that presented with this atypical phenotype
before thymic transplantation [12].
Regarding the origin of DNab T-cells, their reduced sjTREC
levels suggest that they were not produced after transplantation.
Moreover, it is unlikely that they are activated terminally-
differentiated CD8+ T-cells that lost CD8 expression, as suggested
in other clinical settings associated with abnormal expansions of
circulating DNab cells, such as autoimmune lymphoproliferative
syndromes (ALPS) [45], given the lack of expression of markers of
terminal differentiation. The high levels of expression of mucosal-
homing markers suggest an extra-thymic origin of DNab T-cells.
They may have been generated pre-transplant or result from
continuous de novo production. In the latter case their persistence 5
years post-transplantation favors a thymic rather than an extra-
thymic origin since any putative extra-thymic lymphopoiesis is
likely to be shut-down upon thymic transplantation [31]. We
showed that DNab T-cells expressed high levels of IL-2 and IL-7
receptor a-chain and of Bcl-2 suggesting in vivo responsiveness to
IL-7. Our data showing their ability to phosphorylate STAT-5
upon IL-7 or IL-2 stimulation further support this hypothesis. On
the other hand, the low ex vivo frequency of cycling cells, and their
reduced proliferative response to these cytokines, suggest that the
DNab cell maintenance may be largely dependent on cytokine-
induced survival, rather than cytokine-driven expansion.
In order to estimate the functionality of the allogeneic thymic
graft, we took advantage sj/bTREC ratio quantification for the
first time in this context. We found a progressive sj/bTREC
increase in our clinical case, reaching levels comparable to those
observed in healthy children. Importantly, a sharp decline of sj/
bTREC, accompanied by a decrease in sjTREC levels and the
proportion of naı ¨ve cells was observed 4 yrs post-transplantation.
These values plateaued thereafter, illustrating the contribution of
peripheral homeostasis to T cell pool maintenance following its
replenishment, even in the absence of sustained thymic produc-
tion. It is possible that the apparent lack of sustained thymocyte-
division rate (as evidenced by sj/bTREC) resulted from an
intrinsic reduced longevity of the thymus allograft or that the shut-
down of the thymocyte production being a consequence of the
replenishment of the peripheral pool. Given the rarity of FOXN1
deficiency, the underlying factors contributing for the sustainabil-
ity of the thymus allograft could be investigated in future studies on
immunological reconstitution upon thymus transplantation in
cases of DiGeorge syndrome with athymia. The data generated
will be important to appraise the promising use of thymus
transplantation in other clinical contexts.
Overall, our finding of significant numbers of oligoclonal T-cells
in this case of FOXN1-deficiency due to R255X mutation suggest
that, to a certain extent, T-cell development still occurs, albeit with
altered positive/negative selection, as illustrated by the aberrant
expansion of FoxP3+ and DN subsets. Importantly, we showed
that immune-competence can be achieved through HLA-mis-
matched thymic transplantation, in spite of the apparent lack of
long-term functionality of the allogeneic thymic tissue, which has
potential implications for the design of immunological reconstitu-
tion strategies in other clinical settings.
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